A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors

Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to identify patients who are likely to achieve a better and long-lasting response to BRAF inhibitors therapy. In this study, we developed a target...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Louveau, Baptiste, Delyon, Julie, De Moura, Coralie Reger, Battistella, Maxime, Jouenne, Fanelie, Golmard, Lisa, Sadoux, Aurelie, Podgorniak, Marie-Pierre, Chami, Ichrak, Marco, Oren, Caramel, Julie, Dalle, Stephane, Feugeas, Jean-Paul, Dumaz, Nicolas, Lebbe, Celeste, Mourah, Samia
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422198/
https://ncbi.nlm.nih.gov/pubmed/30899440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados